ESR1 and breast carcinoma: Numerous advances have been achieved in the development, selection and application of chemotherapeutic agents, sometimes with remarkable clinical successes, as in the case of treatment of leukemias and lymphomas with combined cytotoxic reagents, testicular cancer with platinum, and estrogen receptor positive breast cancers with Tamoxifen [1].